Aims: Hypertrophied hearts at autopsy often display excessive coronary artery atherosclerosis, but the histopathology of coronary arteries in hearts with and without cardiomegaly has rarely been compared. Methods: In this study, forensic autopsies provided hearts with unexplained enlargement plus comparison specimens. Right coronary artery was opened longitudinally and flattened for formalin fixation and H&E-stained paraffin sections were cut perpendicular to the endothelial surface. The microscopically observed presence or absence of a necrotic atheroma in the specimen was recorded. At multiple sites far removed from any form of atherosclerosis, measurements were taken of intimal thickness, numbers of smooth muscle cells (SMC) and their ratio, the thickness per SMC, averaged over the entire nonatheromatous arterial length. When the mean thickness per SMC exceeded a certain cutoff point, the artery was declared likely to contain a necrotic atheroma. Results: The prevalence of specimens with necrotic atheromas increased stepwise with increasing heart weight, equally with fatal or with incidental cardiomegaly, and equally with hypertension-or obesity-related hypertrophy, rejecting further inclusion of appreciable age, race, or gender effects. The prevalence of specimens with thickness per SMC exceeding the cutoff point was almost always nearly identical to the prevalence of observed necrotic atheroma, showing the two variables to be tightly linked to each other with quantitative consistency across group comparisons of every form. Conclusions: In summary, cardiomegaly, irrespective of the specific cause, seems to accelerate the risk of atheromas, and to do so by first altering the arterial architecture, especially by increasing intimal thickness per SMC. J Atheroscler Thromb, 2011; 18:32-41.
Introduction
When cardiomegaly is encountered at autopsy in the absence of evidence of myocardial lesions, valvular deformities, or other anatomically evident causes, then the condition is usually classed among the cardiomyopathies. The most common of these are ischemic, hypertensive, obesity-related, idiopathic dilated, and hypertrophic cardiomyopathy, as variably defined [1] [2] [3] [4] [5] . When the cause of hypertrophy is determined to be hypertension 6) , obesity [7] [8] [9] [10] , or a combination of the two, then the coronary arteries are expected to display excessive sclerosis. Ischemic cardiomyopathy, clinically recognized, is said to occur upon finding significant coronary stenosis by angiography or noninvasive methods, whether or not this is confirmed by abnor-mal chamber wall motility [2] [3] . Idiopathic dilated cardiomyopathy, clinically recognized, manifests dilated hypertrophy without anatomic cause, hypertension, or obesity [11] [12] [13] , and coronary arteries are generally thought to have little atherosclerosis [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , although contrary evidence has been observed [12] [13] . Recent studies applying newly introduced technologies for quantifying coronary artery calcifications have reported an increased extent of such plaques in relation to cardiac hypertrophy 2, 6, [14] [15] [16] ; however, these studies in living patients were handicapped by the inability to clearly distinguish ischemia from other forms of cardiomyopathy. Whether hypertrophy can itself promote coronary plaques (rather than result from them) therefore remains a persistent question.
Postmortem examination offers some advantages and some shortcomings for exploring the relationships of cardiomegaly to coronary artery sclerosis. Ischemia from coronary artery stenosis is widely thought to produce ventricular hypertrophy only when myocardial scarring interferes with ventricular function, but not otherwise 17) ; hence, inspection of the myocardium for visible lesions should allow for elimination of nearly all instances of ischemic cardiomyopathy. Furthermore, coronary arteries can be examined in gross and histological detail [18] [19] [20] ; however, important clinical information is usually unavailable in forensic autopsies. In the autopsy series to be reported here only a subset of subjects had data on height and weight to use for assessing obesity. No information on blood pressure was available, and evidence of a hypertensive status was extracted from renal histology.
The aging of coronary arteries is accompanied by progressive alterations of their basic architecture throughout sites that are far removed from any form of atherosclerosis. The architectural component of particular interest here, revealed in H&E-stained paraffin sections, is thickening of the intima, which occurs with little or no change in the numbers of smooth muscle cells (SMCs) 19, 20) , so that an increase in the amount of interstitial matrix material occurs per SMC, a quantity abbreviated here as FS, fibroplastic thickness per SMC (excluding atherosclerotic thickening). Much evidence has accumulated to suggest that the likelihood of finding a necrotic atheroma somewhere in the specimen strongly increases with FS in a simple mathematical relationship 19, 20) . When the mean magnitude of FS exceeds a certain defined amount, the probability of finding an atheroma exceeds 50%, and the specimen can be declared likely to contain an atheroma. In this report, any specimen whose mean FS is found to exceed this threshold is said to manifest a "predicted atheroma", a convention adopted to contribute brevity to the exposition and to reduce the sizes of some tables.
Aim
The presence or absence of observed or predicted atheromas is examined here in relation to heart weight in a series of forensic autopsies. The question of central interest is whether cardiomegaly itself might promote observed or predicted atheromas, irrespective of the cause of cardiomegaly, a question that has been raised by accumulating epidemiological evidence 21) .
Methods

Source of material
Specimens of coronary artery were prepared at autopsy from 462 men and women of black and white ethnic groups aged 35-98 years in the Orleans Parish Coroner's Office from 1993-2005, accepting all causes of death except for some selected forms of anatomically evident heart disease, cerebrovascular disease, and aortic aneurysms. A basal category using subjects with causes of death from violence, or natural causes unrelated to hypertension or atherosclerosis, offers an approximation of a representative sample of the population 22) , but this report does not require the use of such a basal group. This autopsy study, omitting patient identifiers, was declared exempt from Internal Review Board review.
Cardiomegaly
The arbitrary cutoff points for defining cardiomegaly were chosen as heart weight 399 grams in women and 449 grams in men. These values correlate well with the values sometimes applied to echocardiographic data as thresholds for diagnosing left ventricular hypertrophy 23) . These values were abstracted from the autopsy protocols without special handling, and are expected to include measurement errors of uncertain magnitude.
Cardiac diagnosis
Coronary heart disease (CHD) was recognized as coronary thrombosis, or myocardial lesions (scars or infarcts) in company with arterial stenosis or occlusion. All instances of CHD were omitted. Also omitted were the few instances of cardiac disorders attributed to valvular deformities, right ventricular abnormalities, and chronic renal disease. In 40 cases the cause of death was determined at autopsy to be left ventricular hypertrophy, usually in the form of dilated cardiomyopathy. These 40 subjects constitute the group of cases referred to as "fatal cardiomegaly" (mean heart weight, 697 grams). Incidental cardiomegaly in the presence of a clearly apparent cause unrelated to cardiovascular disease occurred in 73 cases, 46 instances of death by violence or poisoning and 27 by assorted non-cardiovascular natural diseases (mean heart weight, 501 grams). This group of 73 subjects was designated "incidental cardiomegaly". Hypertrophic cardiomyopathy in its original sense of asymmetric septal hypertrophy marked by myocyte disarray 4) was not encountered in this series.
Processing of specimens
The first 9 cm of each right coronary artery was opened longitudinally, dissected from the heart, compressed by a sponge to flatten for fixation in 4 % acetate-buffered formaldehyde, and cut into 3 to 5 longitudinal segments to be embedded in paraffin on edge to allow sectioning perpendicular to the luminal surface. Sections of 6 m thickness were stained with hematoxylin and eosin (H&E).
Evaluation of slides
Atheromatous necrotic cores, recognized when necessary by cholesterol crystals easily discerned under a 40X objective lens, were marked in black ink on the cover slip. No specific size limit was placed on these in the protocol, but in practice the sizes always exceeded the 100 m width marker incorporated in the observed microscopic field. The variable named YesA was assigned the value of 1 if an atheromatous necrotic core was found anywhere in the specimen; otherwise it was assigned the value of zero. At nine equally spaced positions along the coronary sample (approximately 1 cm separations), excluding black marked locations and sites with microscopically visible fatty streak elements 24) , measurements were taken of intimal and medial thicknesses and counts were made of nuclei, presumed to be nearly all those of smooth muscle cells (SMCs), within a band of 100 m width drawn with an eyepiece reticle through the full intimal and medial thicknesses, as in Fig. 1 (in that figure, SMC numbers (above) and layer thicknesses (below) for these examples are given for intima and media). Means of the fibroplastic thicknesses for intima and media (omitting atheromatous thickening) are called FI and FM, respectively, and their associated SMC numbers are SI and SM. Their ratios, defined as FS FI/ SI and MS FM/SM, denote the amount of matrix material associated with an average SMC, and the FS ratio in particular is of major interest. Sites with an atheromatous necrotic core or fatty streak elements 12) were excluded, but nearly always a nearby location was found to substitute for the otherwise excluded data point. Omission of sites with atherosclerotic features assures that nearly pure populations of SMCs are obtained, without dilution by appreciable numbers of immigrant leukocytes from the blood 25) . Omitting sites with atherosclerosis has the hypothetical possibility of generating a biased sample of the artery that remains to be observed, because the atheroma may not select and censor sites at random. This biasing effect was examined elsewhere in detail 26) , and the only suggested effect was a minor increase in the observed SI in YesA specimens, possibly explained by selective atheromatous censoring of sites with the greatest fibroplasia and the fewest cells; the effect was judged to be negligibly small for the purposes of this report.
Hypertension
Measuring the intimal thickness of interlobular arteries in PAS-stained paraffin sections of renal the cortex provided information for calculating mean arterial pressure (MAP). In a previous series of 236 autopsies 27, 28) , data on mean blood pressure were available from clinical records. Measurements of interlobular arteries in those cases were used to generate a regression equation to use for calculating the predicted 
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clinical MAP, and that equation is now available for application to the current study. By logistic regression analysis, the occurrence of clinically measured hypertension (observed MAP 106.7 mmHg) coincided with predicted hypertension (calculated MAP 106.7 mmHg) in 87 cases, observed normotension coincided with predicted normotension in 91 cases, and the false positive rate was 24.3%, while the false negative rate was 24.8%, odds ratio 9.5. Since blood pressure of 140/90 mm Hg corresponds to MAP 106.7 mmHg, MAP 106.7 mmHg was used in this data set to define hypertension. Renal samples were used in this study to calculate predicted MAP, and it was expected that about 1/4 of the cases in the hypertension category thus defined would be false positives, while 1/4 of the normotensives would be false negatives.
Obesity
Body mass index (BMI) was defined as weight over height squared, and obesity was defined as BMI 29 Kg/m 2 . Only 304 subjects had data on both BMI and calculated MAP, and this subset of cases was used for analyzing these variables.
Predicted atheroma
Measurements of intimal thickness and SMCs counts at sites distant from any form of atherosclerosis can be used to generate the mean ratio FS as defined above. Elevations of this ratio have consistently revealed, under a wide range of conditions, a strong association with the presence of necrotic atheroma somewhere in the specimen 18, 20) . When mean FS 8.873 m/SMC, a quantity derived later, the probability for finding an atheroma somewhere in the specimen exceeds 50%, and the specimen is said to contain a "predicted atheroma" (exemplified by Fig. 1B) .
Statistical analyses
The measure of coronary atherosclerosis of principal interest here is the presence (YesA) or absence (NoA) of necrotic atheroma observed somewhere in the specimen. The SAS package of computer programs (SAS Institute, Cary, NC, USA) was used for analyses. The means of selected variables in the YesA specimens were compared with those in NoA specimens, after adjustment for selected covariates, by PROC GLM. The relationships of YesA (yes/no variable) to predictor variables were examined at the outset by logistic regression, leading to an equation that was used to calculate a second principal quantity called "predicted atheroma". These two variables, observed and predicted atheroma, are dichotomous variables which were compared across groupings according to heart size and across groupings by cardiac diagnosis, using chi square tests for the significance of differences. The influence of heart weight upon these two variables, altered by the inclusion of the covariates, age, race, sex, MAP, and BMI, were tested by logistic regression.
Results
Relations of selected variables to atheroma status
Specimens containing at least one necrotic atheroma (YesA cases) tended to occur at older age, to be more often from white males and the hearts were more often heavier than NoA cases ( Table 1 , YesA and NoA heart weights, respectively, 421 vs 377 grams, adjusted for age, race, and gender). Atheroma-bearing arteries, evaluated at nonatherosclerotic sites distant from any form of atherosclerosis, were also in marked histological contrast to atheroma-free specimens, with special interest in the enhancement of intimal thickness and intimal thickness per SMC (FI and FS, respectively in Table 1 , P 0.001 for both variables). SMCs showed a small but significantly higher number in the same comparison (respectively 25.3 vs 22.9 SMCs per unit cut through the artery wall, P 0.007).
Predictor variables for atheroma status
Univariate logistic regression (models 1 and 2 in Table 2 ) showed both variables, excessive intimal thickness and SMC numbers, to be predictors of atheroma presence, thickness more strongly than SMCs. Taking the two variables together (bivariate model 3), greatly strengthens the thickness effect (beta rising to 3.53 from 2.04 SD units) while reversing the sign of beta for SMC numbers and enhancing its magnitude (the product term, FI SI, is rejected as adding no further significance P 0.21). The ratio, FS FI/SI, serves to indicate how much collagenous matrix is associated with an average SMC in the intima, and this quantity statistically summarizes the prediction of atheroma using both SMC numbers and intimal thickness taken together (Table 2, model 4) . Specimens with the fewest SMCs require the least intimal thickening to exert an effect upon the prediction of atheroma presence while those with the most SMCs require the greatest thickness. Models 3 and 4, assessing the combined effects of FI and SI, generate 2 2 contingency tables; that for model 3 yields an odds ratio of OR 14.8, while the ratio term, FS FI/SI, yields OR 12.8, indicating that the entire action of FI plus SI in this data set is not fully captured by the ratio FS. This difference seems small enough to treat as negligible, and the intuitively meaningful simpler model 4 was chosen for further exploration. By recalculating model 4 using variables in their raw units of measurement, FS 8.873 m/SMC is found as the cutoff point for separating YesA from NoA cases, so that a predicted atheroma is declared to be present if this cutoff is exceeded (i.e. a necrotic atheroma is predicted to be found somewhere in the specimen). This model rejects further entry of age (P 0.108) and heart weight (P 0.053).
Relation of atheroma to heart weight
Percentages of specimens displaying predicted atheroma, as just defined, are recorded in Table 3 within 6 ranges of increasing heart weight. The percentages of specimens revealing at least one observed necrotic atheroma are also shown. The two variables, percentage of cases with predicted and observed atheromas, both repeatedly showed almost perfect stepwise increases as the heart became progressively heavier (Spearman rank order correlation between the 6 pairs of observed and predicted atheromas is r 0.989); the regression between them rejects the additional quadratic term of YesA (P 0.32) implying linearity, although comparing pairs of means by the chi square test indicates that the three largest heart sizes do not differ significantly in either observed or predicted ath- The coefficients here are standardized so that each predictor variable is measured in units of its own standard deviation; raw coefficients can be regenerated using standard deviations in Table 1 , where variables are described. Odds ratio is calculated from the two by two table of classification outcomes.
eroma. It remains ambiguous, therefore, whether atheroma prevalence reached a limit as heart sizes approach the extreme of their upper range.
Relations of atheroma to cardiac diagnosis
Of the 114 specimens with cardiomegaly, 40 were classed as cause of death and 74 as incidental accompaniment of some other conspicuous cause of death, usually violence (46 cases). When compared with subjects lacking cardiomegaly, both categories of cardiomegaly were conspicuously similar in displaying nearly identical increases in the prevalence of atheromas, and also preserving the near identity of observed with predicted atheromas in all comparisons ( Table 4) .
Relations of hypertension and obesity to cardiomegaly
In the subset of 304 subjects with data on body mass index (BMI kg/m 2 ) and renal-derived information on mean arterial pressure (MAP, mm Hg), the percentages classed as obese were 23.4, 63.0, and 60.9% (P 0.001) and the percentages classed as hypertensive were 28.6, 55.6, and 50.0 % (P 0.001), respectively, in the three cardiac diagnosis categories in Table 4 . The two categories of cardiomegaly were Predicted atheroma is defined as FS 8.873 m/SMC. Heart weights were recorded to with 10 grams. Tabulated percentages were used to calculate numbers of YesA and NoA cases in each of the six heart size categories, thereby generating a 2 6 continency matrix for each column, and chi square tests rejected randomness of atheroma dispersion in both of these matrices. Pairs within a column that fail to share a symbol A, B, C, or D differ significantly at P 0.05 by chi square test. Table 3  See footnote Table 3 . With three categories of cardiac condition, the contingency matrices for chi square testing are 2 3 in each column. Number of cases 462 includes those with missing data on hypertension and obesity. Number of cases 304 includes only those with complete data. nearly identical in the relevant comparisons. The 20 cardiomegaly cases of both hypertension and obesity had equal prevalence to the cases of either hypertension or obesity alone, and these cases are therefore not detailed in Table 4 . These findings point to about equal elevated incidences of hypertension and obesity among cardiomegaly cases.
Relations of atheroma prevalence to MAP and BMI
By logistic regression analysis, mean arterial pressure (MAP) was significantly associated with necrotic atheroma prevalence, both observed and predicted, adjusted for heart weight (model 2 in Table 5 , P 0.01 and P 0.001 respectively). Body mass index (BMI) had no significant association with atheroma, either observed or predicted, after adjustment for heart weight (P 0.50 and P 0.27, respectively, model 2 in Table 5 ). The beta coefficient relating heart weight to observed atheroma (0.50, model 1 in Table  5 ) was unaffected by adjusting for MAP and BMI (0.50, model 2). Similarly, the beta for predicted atheroma was almost unchanged (0.38 vs 0.40). These are the expected results if the heart weight effect is similar whether correlated with hypertension or obesity or some other unidentified agent.
Relationship of atheroma to heart weight adjusted for age, race, and gender
These adjustments are introduced in model 3 in Table 5 . In this multivariate setting, race and gender had negligibly small effects on observed and predicted atheroma prevalences, while age was strongly related to atheromas of both types. The beta coefficient relating heart weight to observed atheroma (0.50, model 1 in Table 5 ) was little changed by adjusting for age, race, and gender (0.40, model 3). The same outcome was obtained for predicted atheroma (beta declining from 0.38 to 0.32). Although a small component of heart weight association with atheroma seems to arise from their common correlation with age, the effect is Table 2 . MAP is mean arterial pressure and BMI is body mass index. Beta does not differ significantly from zero with the specified p level.
small, as expected if heart weight has almost identical associations with atheromas at all ages.
SMC numbers
The mean number of intimal SMCs (SI in Tables 1 and 2) in the three cardiac diagnosis categories of Table 4 
Discussion
In the present data set, cardiomegaly is seen to display a strong association with the likelihood of finding necrotic atheroma, either observed or predicted, in the right coronary artery ( Table 3) . It is assumed here that nearly all cases of ischemic cardiomyopathy should be eliminated by finding postmortem evidence of coronary thrombosis or visible ischemic lesions in the myocardium 2, 3, 17) . To the extent that this assumption may be false, the following conclusions must be viewed with caution.
Hypertension and obesity were far more common in the groups with cardiomegaly than in the group lacking a cardiac diagnosis, and these agents are likely candidates causing excessive heart weights 29) . However, the data reviewed here seem to implicate only hypertension, and not obesity, as a serious additional factor in the coexistence of atheromas in hypertrophied hearts, because the introduction of MAP to the logistic regression model significantly improved the forecasting of atheroma, while BMI had no such effect ( Table 5 , model 2). Furthermore, the introduction of MAP and BMI had no influence on the persistent relationship of heart weight to atheroma presence ( Table 5 , models 1 and 2 both report beta 0.50 for heart weight). This evidence taken together suggests that heart weight itself may have independent activity for directly promoting atheroma, whether the cardiomegaly results from hypertension, obesity, or other unidentified causes. Clinical studies of coronary calcifications have found similar results, with heart size retaining a persistent correlation with coronary plaques after adjusting for numerous covariates, including blood pressure and obesity 6, 9) . The entity here assigned the name "predicted atheroma" refers to a property of the age-altered basic architecture of the artery, recognized by an excess of mean intimal fibroplasia per SMC, FS, at sites lacking any form of atherosclerosis (Fig. 1B) . The data tabulated here reiterate prior reports 18, 20) showing that the mean magnitude of FS displays a strong linear association with the probability of finding a necrotic atheroma somewhere in the specimen ( Table 2) . Furthermore, the probability of finding observed atheromas varies across group comparisons in nearly perfect parallel with comparable variations of predicted atheromas (Tables 3 & 4) . The enhanced probability of finding an observed or predicted atheroma in the coronary artery that accompanies cardiomegaly appears to occur in all enlarged hearts, irrespective of the cause of hypertrophy in these selected classes. Obesity in particular shows evidence of enhancing atheroma only in those obese subjects that manifest cardiomegaly.
It has been proposed that sufficient increases of FS in aging coronary arteries can act to promote the sequestration of collagen-linked interstitial lipid 30) and evolution to atheroma 20, 26, 30) . Therefore, if enlarged arteries that grow bigger along with the hypertrophying heart should accelerate the progression of FS, then the enhancement of atheromas could be explained.
It is generally accepted that little if any increase in cardiac myocyte numbers occurs during ventricular hypertrophy. Perhaps something similar may be in operation in the intimal SMC population of coronary arteries 31) . These cells can proliferate after injury in the process of wound healing, but this is unlikely to be what is happening in natural aging 26, 31) . The numbers of intimal SMCs in the coronary arteries of this study showed little if any increase with cardiomegaly; rather, the data showed an expansion of the collagenous matrix, thereby thickening the arterial intima in company with a nearly stable population of SMCs. SMC numbers therefore appear to increase little or not at all with the coronary enlargement of cardiomegaly, irrespective of its cause, thereby leaving the intima with an enhanced mass of matrix insufficiently supported by overly few SMCs.
This study has a number of serious limitations that are inherent in studies of forensic material. These include the absence of clinical information about dyslipidemia, diabetes, smoking alcoholism, and metabolic diseases. Also, the measure of hypertension is confined to an undesirable range of false positives and negatives. Of particular concern is the uncertainty that instances of ischemic cardiomyopathy have been suffi-ciently eliminated; however, the histological data under inquiry are accessible only in autopsy materials, and forensic material has the unique advantage of offering instances of death by violence or poisoning allowing, observation of the histology unaltered by other complicating diseases. These limitations need to be tolerated in order to perform a study. The findings should be held as tentative working hypotheses.
Conclusions
When hearts are examined at autopsy, it is possible that the evidence used to recognize ischemic cardiomyopathy is sufficiently reliable so that nearly all instances of this condition are eliminated. This would offer the opportunity to avoid the possible mischief from ascribing to a primary coronary disease the finding of an increased likelihood of coronary plaques with cardiomegaly. The data cautiously introduced here point to a correlation of atheromas with heart weight that is independent of the specific cause of cardiac enlargement. It could be, therefore, that enlarging coronary arteries in the hypertrophied heart are not exhibiting physiological growth, but rather a form of pathological ectasia, marked especially by an increased amount of fibroplastic matrix per SMC, and that this might bear upon the correlation of heart size with coronary atheromas.
